Overview

A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The hypothesis was to establish whether the use of PrevinC administered nasally 2-3 times a day will prevent upper respiratory infections in otherwise healthy adults working in child day care centers.
Phase:
Phase 4
Details
Lead Sponsor:
BioHealth Technologies Inc.